| 1 |
Ward KK, Mchale MT. Uterine corpus cancers//Eskander RN, Bristow RE. Gynecologic oncology[M]. New York:Springer, 2015: 133-174.
|
| 2 |
孙馥箐，段华．子宫内膜癌保留生育功能治疗的现状与存在的问题[J]．中国微创外科杂志，2015，15(1)：73-76.
|
| 3 |
Kim MK, Yoon BS, Park H, et al. Conservative treatment with medroxyprogesterone acetate plus levonorgestrel intrauterine system for early-stage endometrial cancer in young women pilot study[J]. Int J Gynecol Cancer, 2011, 21(4): 673-677.
|
| 4 |
Vandenput I, Van Eygen K, Moerman P, et al. Ineffective attempt to preserve fertility with a levonorgestrel-releasing intrauterine device in a young woman with endometrioid endometrial carcinoma: a case report and review of the literature[J]. Eur J Gynaecol Oncol, 2009, 30(3): 313-316.
|
| 5 |
Koh WJ, Greer BE, Abu-Rustum NR, et al. The NCCN endometrial neoplasm clinical practice guidelines in oncology (version 2.2016)[EB/OL]. [2015-12-01].
URL
|
| 6 |
Carp HJA. Progestogens in obstetrics and gynecology[M]. Switzerland:Springer, 2015: 159.
|
| 7 |
Moe BT, Vereide AB, Orbo A, et al. Levonorgestrel, medroxyprogesterone and progesterone cause a concentration-dependent reduction in endometrial cancer (Ishikawa) cell density, and high concentrations of progesterone and mifepristone act in synergy[J]. Anticancer Res, 2009, 29(4): 1047-1052.
|
| 8 |
Zhao X, Tang X, Ma T, et al. Levonorgestrel inhibits human endometrial cell proliferation through the upregulation of gap junctional intercellular communication via the nuclear translocation of Ser255 phosphorylated Cx43[J]. Biomed Res Int, 2015: 758684.
|
| 9 |
郄明蓉，张竹．子宫内膜癌患者保留卵巢功能的探讨[J/CD]．中华妇幼临床医学杂志：电子版，2014，10(5)：565-567.
|
| 10 |
中华医学会妇科肿瘤学分会．妇科恶性肿瘤保留生育功能临床诊治指南[J]．中华医学信息导报，2014，49(4)：243-247.
|
| 11 |
Kalogera E, Dowdy SC, Bakkum-Gamez JN, et al. Preserving fertility in young patients with endometrial cancer: current perspectives[J].Int J Womens Health, 2014, 6: 691-701.
|
| 12 |
Song T, Seong SJ, Bae DS, et al. Synchronous primary cancers of the endometrium and ovary in young women: a Korean Gynecologic Oncology Group Study[J]. Gynecol Oncol, 2013, 131(3): 624-628.
|
| 13 |
Walsh C, Holschneider C, Hoang Y, et al. Coexisting ovarian malignancy in young women with endometrial cancer[J]. Obstet Gynecol, 2005, 106(4): 693-699.
|
| 14 |
吕斯迹，殷怡华．孕激素在子宫内膜癌前期病变和子宫内膜癌中的应用[J]．世界临床药物，2014，35(11)：655-658.
|
| 15 |
Laurelli G, Di Vagno G, Scaffa C, et al. Conservative treatment of early endometrial cancer: preliminary results of a pilot study[J]. Gynecol Oncol, 2011, 120(1): 43-46.
|
| 16 |
Fambrini M, Bargelli G, Peruzzi E, et al. Levonorgestrel-releasing intrauterine system alone as primary treatment in young women with early endometrial cancer: case report[J]. J Minim Invasive Gynecol, 2009, 16(5): 630-633.
|
| 17 |
Cade TJ, Quinn MA, Rome RM, et al. Long-term outcomes after progestogen treatment for early endometrial cancer[J]. Aust N Z J Obstet Gynaecol, 2013, 53(6): 566-570.
|
| 18 |
Brown AJ, Westin SN, Broaddus RR, et al. Progestin intrauterine device in an adolescent with grade 2 endometrial[J].Obstet Gynecol, 2012, 119(2 Pt 2): 423-426.
|
| 19 |
Minig L, Franchi D, Boveri S, et al. Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young women[J]. Ann Oncol, 2011, 22(3): 643-649.
|
| 20 |
Kim MK, Seong SJ, Kim YS, et al. Combined medroxyprogesterone acetate/levonorgestrel-intrauterine system treatment in young women with early-stage endometrial cancer[J]. Am J Obstet Gynecol, 2013, 209(4): 358. e1-e4.
|
| 21 |
Wildemeersch D, Anderson E, Lambein K, et al. Successful treatment of early endometrial carcinoma by local delivery of levonorgestrel: a case report[J]. Obstet Gynecol Int, 2010: 431950.
|
| 22 |
陈亮，杜雪莲，张师前．子宫内膜癌保留生育功能的研究进展[J/CD]．中华临床医师杂志：电子版，2015，9(1)：47-51.
|
| 23 |
Kim MK, Seong SJ, Song T, et al. Comparison of dilatation & curettage and endometrial aspiration biopsy accuracy in patients treated with high-dose oral progestin plus levonorgestrel intrauterine system for early-stage endometrial cancer[J]. Gynecol Oncol, 2013, 130(3): 470-473.
|